東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

New therapies in advanced cutaneous ...

Rutkowski, Piotr.

Linked to FindBook

Google Book

Amazon

博客來

New therapies in advanced cutaneous malignancies

Record Type:	Electronic resources : Monograph/item
Title/Author:	New therapies in advanced cutaneous malignancies/ edited by Piotr Rutkowski, Mario Mandala.
other author:	Rutkowski, Piotr.
Published:	Cham :Springer International Publishing : : 2021.,
Description:	xiv, 457 p. :ill. (some col.), digital ;24 cm.
[NT 15003449]:	Part 1. Pathological, molecular and immunological background of Cutaneous Malignancies -- Pathology of Melanoma and Skin Carcinomas -- Molecular Landscape Profile of Melanoma -- Molecular Landscape of Skin Carcinomas -- Immunological Features of Melanoma -- Part 2. Targeted Therapies in Skin Cancers -- Dabrafenib and Trametinib -- Vemurafenib and Cobimetinib -- Encorafenib and Binimetinib -- Vismodegib -- Sonidegib -- Part 3. Immunological Strategies in Advanced Melanoma -- Ipilimumab -- Nivolumab -- Pembrolizumab -- Talimogene Leharparepvec -- Part 4. Future of Melanoma Immunotherapy -- Perspectives of Immunotherapy in Advanced Melanoma Combinations and Sequencing -- Part 5. Immunological Therapies in Advanced Skin Carcinomas -- Avelumab -- Cemiplimab -- Perspectives of Immunotherapy in Non-Melanoma Skin Cancers -- Part 6. Mechanism of Resistance to Therapy -- Mechanisms of Resistance to Targeted Therapies in Skin Cancer -- Mechanisms of Resistance to Immunotherapy -- Part 7. Perioperative Therapy of Melanoma -- Neoadjuvant and Adjuvant Therapy in Melanoma -- Part 8. Special Techniques and Populations -- Adoptive Cell Therapy Immunological Therapies in Special Populations: HIV, Hepatitis and Organ Transplantation -- Conclusions.
Contained By:	Springer Nature eBook
Subject:	Skin - Cancer -
Online resource:	https://doi.org/10.1007/978-3-030-64009-5
ISBN:	9783030640095

New therapies in advanced cutaneous malignancies
New therapies in advanced cutaneous malignancies[electronic resource] /edited by Piotr Rutkowski, Mario Mandala. - Cham :Springer International Publishing :2021. - xiv, 457 p. :ill. (some col.), digital ;24 cm.

Part 1. Pathological, molecular and immunological background of Cutaneous Malignancies -- Pathology of Melanoma and Skin Carcinomas -- Molecular Landscape Profile of Melanoma -- Molecular Landscape of Skin Carcinomas -- Immunological Features of Melanoma -- Part 2. Targeted Therapies in Skin Cancers -- Dabrafenib and Trametinib -- Vemurafenib and Cobimetinib -- Encorafenib and Binimetinib -- Vismodegib -- Sonidegib -- Part 3. Immunological Strategies in Advanced Melanoma -- Ipilimumab -- Nivolumab -- Pembrolizumab -- Talimogene Leharparepvec -- Part 4. Future of Melanoma Immunotherapy -- Perspectives of Immunotherapy in Advanced Melanoma Combinations and Sequencing -- Part 5. Immunological Therapies in Advanced Skin Carcinomas -- Avelumab -- Cemiplimab -- Perspectives of Immunotherapy in Non-Melanoma Skin Cancers -- Part 6. Mechanism of Resistance to Therapy -- Mechanisms of Resistance to Targeted Therapies in Skin Cancer -- Mechanisms of Resistance to Immunotherapy -- Part 7. Perioperative Therapy of Melanoma -- Neoadjuvant and Adjuvant Therapy in Melanoma -- Part 8. Special Techniques and Populations -- Adoptive Cell Therapy Immunological Therapies in Special Populations: HIV, Hepatitis and Organ Transplantation -- Conclusions.

This book provides a detailed overview of the activity and efficacy of new treatments and promising perspectives in the field of cutaneous malignancies. The first part of the book covers the basic molecular and immunological mechanisms. It then goes on to cover specific strategies in melanoma and non-melanoma skin cancers that, starting from the basic mechanisms, translate this information into clinical routine or translational research. This unique handbook comprises very practical structured descriptions of more than 10 new agents used in treatment of melanomas and skin carcinomas together with biological background of their mechanisms of action. It provides structured and up-to-date information about all therapeutics in cutaneous malignancies, making it extremely useful in clinical practice, for clinicians that need timely and focused information. Prepared by a group of international authors from expert melanoma centres in Europe, the book provides knowledge distilled from the diverse perspectives of the contributing authors (pathologists, translational scientists and clinicians) This book is of interest to medical oncologists, oncological surgeons, dermatologists and immunologists as well as biologists and pharmacologists.

ISBN: 9783030640095

Standard No.: 10.1007/978-3-030-64009-5doiSubjects--Topical Terms:

1066988
Skin
--Cancer

LC Class. No.: RC280.S5

Dewey Class. No.: 616.99477

New therapies in advanced cutaneous malignancies
LDR:03484nmm a2200325 a 4500 001 2238499
003 DE-He213
005 20210217061523.0
006 m d
007 cr nn 008maaau
008 211111s2021 sz s 0 eng d
020 $a 9783030640095 $q (electronic bk.)
020 $a 9783030640088 $q (paper)
024 7 $a 10.1007/978-3-030-64009-5 $2 doi
035 $a 978-3-030-64009-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.S5
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99477 $2 23
090 $a RC280.S5 $b N532 2021
245 0 0 $a New therapies in advanced cutaneous malignancies $h [electronic resource] / $c edited by Piotr Rutkowski, Mario Mandala.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xiv, 457 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part 1. Pathological, molecular and immunological background of Cutaneous Malignancies -- Pathology of Melanoma and Skin Carcinomas -- Molecular Landscape Profile of Melanoma -- Molecular Landscape of Skin Carcinomas -- Immunological Features of Melanoma -- Part 2. Targeted Therapies in Skin Cancers -- Dabrafenib and Trametinib -- Vemurafenib and Cobimetinib -- Encorafenib and Binimetinib -- Vismodegib -- Sonidegib -- Part 3. Immunological Strategies in Advanced Melanoma -- Ipilimumab -- Nivolumab -- Pembrolizumab -- Talimogene Leharparepvec -- Part 4. Future of Melanoma Immunotherapy -- Perspectives of Immunotherapy in Advanced Melanoma Combinations and Sequencing -- Part 5. Immunological Therapies in Advanced Skin Carcinomas -- Avelumab -- Cemiplimab -- Perspectives of Immunotherapy in Non-Melanoma Skin Cancers -- Part 6. Mechanism of Resistance to Therapy -- Mechanisms of Resistance to Targeted Therapies in Skin Cancer -- Mechanisms of Resistance to Immunotherapy -- Part 7. Perioperative Therapy of Melanoma -- Neoadjuvant and Adjuvant Therapy in Melanoma -- Part 8. Special Techniques and Populations -- Adoptive Cell Therapy Immunological Therapies in Special Populations: HIV, Hepatitis and Organ Transplantation -- Conclusions.
520 $a This book provides a detailed overview of the activity and efficacy of new treatments and promising perspectives in the field of cutaneous malignancies. The first part of the book covers the basic molecular and immunological mechanisms. It then goes on to cover specific strategies in melanoma and non-melanoma skin cancers that, starting from the basic mechanisms, translate this information into clinical routine or translational research. This unique handbook comprises very practical structured descriptions of more than 10 new agents used in treatment of melanomas and skin carcinomas together with biological background of their mechanisms of action. It provides structured and up-to-date information about all therapeutics in cutaneous malignancies, making it extremely useful in clinical practice, for clinicians that need timely and focused information. Prepared by a group of international authors from expert melanoma centres in Europe, the book provides knowledge distilled from the diverse perspectives of the contributing authors (pathologists, translational scientists and clinicians) This book is of interest to medical oncologists, oncological surgeons, dermatologists and immunologists as well as biologists and pharmacologists.
650 0 $a Skin $x Cancer $x Treatment. $3 1066988
650 1 4 $a Oncology. $3 751006
650 2 4 $a Dermatology. $3 829009
650 2 4 $a Immunology. $3 611031
700 1 $a Rutkowski, Piotr. $3 3491698
700 1 $a Mandala, Mario. $3 3491699
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-64009-5
950 $a Medicine (SpringerNature-11650)